Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
A Phase I Study Of Myeloablative Radioimmunotherapy Using Iodine-131 Anti-CD45 Antibody Followed By Autologous Stem Cell Transplantation For High-Risk B-Cell and T-Cell Non-Hodgkin Lymphoma and Hodgkin Lymphoma
Blood (2013)
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Joseph G. Rajendran, University of Washington
  • Theodore A. Gooley, Fred Hutchinson Cancer Research Center
  • Darrell R. Fisher, Pacific Northwest National Laboratory
  • Sally J. Lundberg, Fred Hutchinson Cancer Research Center
  • Lacey M. Hedin, Fred Hutchinson Cancer Research Center
  • Andrew T. Shields, University of Washington
  • Damian J. Green, Fred Hutchinson Cancer Research Center
  • Robert S. Miyaoka, University of Washington
  • Frederick R. Appelbaum, University of Washington
  • Ajay K. Gopal, University of Washington
Link
Disciplines
Publication Date
November 15, 2013
Citation Information
Oliver W. Press, John M. Pagel, Joseph G. Rajendran, Theodore A. Gooley, et al.. "A Phase I Study Of Myeloablative Radioimmunotherapy Using Iodine-131 Anti-CD45 Antibody Followed By Autologous Stem Cell Transplantation For High-Risk B-Cell and T-Cell Non-Hodgkin Lymphoma and Hodgkin Lymphoma" Blood Vol. 122 Iss. 21 (2013) p. 3333 - 3333
Available at: http://works.bepress.com/john-pagel/121/